Barin Feroz

7PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Early Normalization of Squamous Cell Carcinoma Antigen During Combined Chemoradiation Predicts Pathological Response and Survival in Squamous Cervical Cancer: A Retrospective Cohort Study.

|Apr 01, 2026
Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer.

Barin Feroz, Christoph Ebner, Sergej Skvortsov

|Dec 22, 2025
Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.

Christoph Ebner, Ricarda Purtscheller, Barin Feroz

|Dec 11, 2025
The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of TP53-Mutated High-Grade Serous Ovarian Cancer.

Katharina Steger, Heidelinde Fiegl, Katja Rungger

|Jun 13, 2025
Comparison of Efficacy and Safety of Cryotherapy in Chemotherapy-Induced Peripheral Neuropathy Between Upper and Lower Extremities: Results from the Randomized CROPSI Study.

Miriam Emmelheinz, Christian Marth, Daniel Egle

|Jul 05, 2024
Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome.

Barin Feroz, Teresa L Pan, Katharina Leitner

Pageof 2

Frequent Collaborators

5 joint publications

Katharina Leitner

4 joint publications

Christoph Ebner

3 joint publications

Katharina Steger

3 joint publications

Irina Tsibulak